Age related changes in metabolite concentrations in the normal spinal cord

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Abdel Aziz, Khaled ^a   Solanky, Bhavana S ^a   Yiannakas, Marios C ^a   Altmann, Daniel R ^b   Wheeler Kingshott, Claudia A M ^a   Thompson, Alan J ^a,c   Ciccarelli, Olga ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; ASPARTIC ACID; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUCOSE; GLUTAMATE GLUTAMINE; GLUTAMIC ACID; GLUTAMINE; GUANIDINOACETIC ACID; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; NEUROTRANSMITTER; PHOSPHORYLCHOLINE; TAURINE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AGING; ARTICLE; CERVICAL SPINAL CORD; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSPECTIVE STUDY; VOXEL BASED MORPHOMETRY; METABOLISM; MIDDLE AGED; REFERENCE VALUE; SPINAL CORD; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGING; ASPARTIC ACID; CHOLINE; CREATINE; FEMALE; GLUTAMIC ACID; GLUTAMINE; HEALTHY VOLUNTEERS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; REFERENCE VALUES; SPINAL CORD; YOUNG ADULT;

EID: 84907897517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105774     Document Type: Article

References (80)

1. Wolfson L, Whipple R, Amerman P, Tobin JN (1990) Gait Assessment in the Elderly - a Gait Abnormality Rating-Scale and Its Relation to Falls. Journals of Gerontology 45: M12-M19.
2. Murray MP, Kory RC, Clarkson BH (1969) Walking Patterns in Healthy Old Men. Journals of Gerontology 24: 169-&.
3. Deneeling JND, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM (1994) Sensory Thresholds in Older Adults - Reproducibility and Reference Values. Muscle Nerve 17: 454-461.
4. Ferrell WR, Crighton A, Sturrock RD (1992) Age-Dependent Changes in Position Sense in Human Proximal Interphalangeal Joints. Neuroreport 3: 259-261.
5. Robbins S, Waked E, Mcclaran J (1995) Proprioception and Stability - Foot Position Awareness as a Function of Age and Footwear. Age and Ageing 24: 67-72.
6. Mufson EJ, Stein DG (1980) Degeneration in the spinal cord of old rats. Exp Neurol 70: 179-186.
7. Marcio J, Jorge N, Wexner SD (1993) Etiology and Management of Fecal Incontinence. Diseases of the Colon & Rectum 36: 77-97.
8. Siroky MB (2004) The aging bladder. Rev Urol 6 Suppl 1: S3-7.
9. Kaiser FE (1999) Erectile dysfunction in the aging man. Medical Clinics of North America 83: 12672+.
10. Aversa A, Bruzziches R, Francomano D, Natali M, Gareri P, et al. (2010) Endothelial dysfunction and erectile dysfunction in the aging man. International Journal of Urology 17: 38-47.
11. Burek JD, van der Kogel AJ, Hollander CF (1976) Degenerative myelopathy in three strains of aging rats. Vet Pathol 13: 321-331.
12. Cruz-Sanchez FF, Moral A, Tolosa E, de Belleroche J, Rossi ML (1998) Evaluation of neuronal loss, astrocytosis and abnormalities of cytoskeletal components of large motor neurons in the human anterior horn in aging. Journal of Neural Transmission 105: 689-701.
13. Nonaka N, Goto N, Goto J, Shibata M, Nakamura M (2008) Morphometric evaluation of the aging process in various human nerve fibers. Okajimas Folia Anat Jpn 85: 103-106.
14. Corbin KB, Gardner ED (1937) Decrease in number of myelinated fibers in human spinal roots with age. Anatomical Record 68: 63-74.
15. Agosta F, Lagana M, Valsasina P, Sala S, Dall'Occhio L, et al. (2007) Evidence for cervical cord tissue disorganisation with aging by diffusion tensor MRI. Neuroimage 36: 728-735.
16. Thorpe JW, Kidd D, Kendall BE, Tofts PS, Barker GJ, et al. (1993) Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults. Neurology 43: 2625-2631.
17. Lycklama a Nijeholt GJ, Barkhof F, Scheltens P, Castelijns JA, Ader H, et al. (1997) MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol 18: 1041-1048.
18. Suzuki M, Shimamura T (1994) [Morphological study of the axial view of the cervical spinal cord by MR images]. Nihon Seikeigeka Gakkai Zasshi 68: 1-13.
19. Ishikawa M, Matsumoto M, Fujimura Y, Chiba K, Toyama Y (2003) Changes of cervical spinal cord and cervical spinal canal with age in asymptomatic subjects. Spinal Cord 41: 159-163.
20. Tanaka Y (1984) [Morphological changes of the cervical spinal canal and cord due to aging]. Nihon Seikeigeka Gakkai Zasshi 58: 873-886.
21. Sherman JL, Nassaux PY, Citrin CM (1990) Measurements of the normal cervical spinal cord on MR imaging. AJNR Am J Neuroradiol 11: 369-372.
22. Stroman PW, Wheeler-Kingshott C, Bacon M, Schwab JM, Bosma R, et al. (2014) The current state-of-the-art of spinal cord imaging: Methods. Neuroimage 84: 1070-1081.
23. Moreno-Torres A, Pujol J, Soriano-Mas C, Deus J, Iranzo A, et al. (2005) Age-related metabolic changes in the upper brainstem tegmentum by MR spectroscopy. Neurobiol Aging 26: 1051-1059.
24. Zahr NM, Mayer D, Pfefferbaum A, Sullivan EV (2008) Low striatal glutamate levels underlie cognitive decline in the elderly: Evidence from in vivo molecular spectroscopy. Cereb Cortex 18: 2241-2250.
25. Sailasuta N, Ernst T, Chang L (2008) Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging 26: 667-675.
26. Chang L, Jiang CS, Ernst T (2009) Effects of age and sex on brain glutamate and other metabolites. Magn Reson Imaging 27: 142-145.
27. Haga KK, Khor YP, Farrall A, Wardlaw JM (2009) A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging 30: 353-363.
28. Harris JL, Yeh HW, Swerdlow RH, Choi IY, Lee P, et al. (2014) High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging. Neurobiol Aging.
29. Cooke FJ, Blamire AM, Manners DN, Styles P, Rajagopalan B (2004) Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magn Reson Med 51: 1122-1128.
30. Marliani AF, Clementi V, Albini-Riccioli L, Agati R, Leonardi M (2007) Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 tesla. Magnetic Resonance in Medicine 57: 160-163.
31. Holly LT, Freitas B, McArthur DL, Salamon N (2009) Proton magnetic resonance spectroscopy to evaluate spinal cord axonal injury in cervical spondylotic myelopathy. J Neurosurg Spine 10: 194-200.
32. Ciccarelli O, Altmann DR, McLean MA, Wheeler-Kingshott CA, Wimpey K, et al. (2010) Spinal cord repair in MS: does mitochondrial metabolism play a role? Neurology 74: 721-727.
33. Carew JD, Nair G, Andersen PM, Wuu J, Gronka S, et al. (2011) Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Neurology 77: 1370-1375.
34. Marliani AF, Clementi V, Albini Riccioli L, Agati R, Carpenzano M, et al. (2010) Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 31: 180-184.
35. Kachramanoglou C, De Vita E, Thomas DL, Wheeler-Kingshott CA, Balteau E, et al. (2013) Metabolic Changes in the Spinal Cord After Brachial Plexus Root Re-implantation. Neurorehabil Neural Repair 27: 118-124.
36. Yiannakas MC, Kearney H, Samson RS, Chard DT, Ciccarelli O, et al. (2012) Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: A pilot study with application to magnetisation transfer measurements. Neuroimage 63: 1054-1059.
37. Solanky BS, Abdel-Aziz K, Yiannakas MC, Berry AM, Ciccarelli O, et al. (2013) In vivo magnetic resonance spectroscopy detection of combined glutamate-glutamine in healthy upper cervical cord at 3 T. NMR Biomed 26: 357-366.
38. Phlips-Manual (2009) Application guide volume 4: Spectroscopy. Achieva Release Series 3: Philips Medical Systems, Netherland.
39. Kendi AT, Tan FU, Kendi M, Yilmaz S, Huvaj S, et al. (2004) MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 46: 764-769.
40. Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, et al. (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342: 163-166.
41. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679.
42. Smith SA, Levante TO, Meier BH, Ernst RR (1994) Computer-Simulations in Magnetic-Resonance - an Object-Oriented Programming Approach. Journal of Magnetic Resonance Series A 106: 75-105.
43. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, et al. (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55: 1219-1226.
44. Provencher SW (2014) LCModel & LCMgui User's Manual. http://sprovencher.com/pub/LCModel/manual/manual.pdf.
45. Gomez-Anson B, MacManus DG, Parker GJ, Davie CA, Barker GJ, et al. (2000) In vivo 1H-magnetic resonance spectroscopy of the spinal cord in humans. Neuroradiology 42: 515-517.
46. Henning A, Schar M, Kollias SS, Boesiger P, Dydak U (2008) Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med 59: 1250-1258.
47. Clarke DD, Greenfield S, Dicker E, Tirri LJ, Ronan EJ (1975) A relationship of N-acetylaspartate biosynthesis to neuronal protein synthesis. J Neurochem 24: 479-485.
48. Patel TB, Clark JB (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184: 539-546.
49. Truckenmiller ME, Namboodiri MA, Brownstein MJ, Neale JH (1985) N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 45: 1658-1662.
50. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM (2007) NAcetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81: 89-131.
51. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD (2000) Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48: 893-901.
52. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, et al. (1996) Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 7: 1397-1400.
53. Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF (2002) High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet 11: 133-145.
54. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58: 495-505.
55. Gupta A, Hasan M, Chander R, Kapoor NK (1991) Age-related elevation of lipid peroxidation products: diminution of superoxide dismutase activity in the central nervous system of rats. Gerontology 37: 305-309.
56. Keller JN, Mattson MP (1998) Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 9: 105-116.
57. Butler D, Bahr BA (2006) Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy. Antioxid Redox Signal 8: 185-196.
58. Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Patterson LJ, et al. (1994) Proton spectroscopy of human brain: effects of age and sex. Prog Neuropsychopharmacol Biol Psychiatry 18: 995-1004.
59. Lim KO, Spielman DM (1997) Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 37: 372-377.
60. Brooks JC, Roberts N, Kemp GJ, Gosney MA, Lye M, et al. (2001) A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex 11: 598-605.
61. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM (1999) Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging 9: 711-716.
62. Chang L, Ernst T, Poland RE, Jenden DJ (1996) In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 58: 2049-2056.
63. Ge YL, Grossman RI, Babb JS, Rabin ML, Mannon LJ, et al. (2002) Age-related total gray matter and white matter changes in normal adult brain. Part I: Volumetric MR imaging analysis. American Journal of Neuroradiology 23: 1327-1333.
64. Kadota T, Horinouchi T, Kuroda C (2001) Development and aging of the cerebrum: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 22: 128-135.
65. Grillner S, Wallen P, Saitoh K, Kozlov A, Robertson B (2008) Neural bases of goal-directed locomotion in vertebrates - An overview. Brain Research Reviews 57: 2-12.
66. Todd AJ (2010) Neuronal circuitry for pain processing in the dorsal horn. Nature Reviews Neuroscience 11: 823-836.
67. Baker EH, Basso G, Barker PB, Smith MA, Bonekamp D, et al. (2008) Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging 27: 489-499.
68. Kaiser LG, Schuff N, Cashdollar N, Weiner MW (2005) Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T. Neurobiol Aging 26: 665-672.
69. Muhlert N, Atzori M, De Vita E, Thomas DL, Samson RS, et al. (2014) Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry.
70. Schubert F, Gallinat J, Seifert F, Rinneberg H (2004) Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 21: 1762-1771.
71. Choi C, Coupland NJ, Bhardwaj PP, Kalra S, Casault CA, et al. (2006) T2 measurement and quantification of glutamate in human brain in vivo. Magn Reson Med 56: 971-977.
72. O'Gorman RL, Michels L, Edden RA, Murdoch JB, Martin E (2011) In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects. J Magn Reson Imaging 33: 1262-1267.
73. Zahr NM, Mayer D, Rohlfing T, Chanraud S, Gu M, et al. (2013) In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging. Neurobiol Aging 34: 1265-1276.
74. Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, et al. (2008) Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biol Psychiatry 63: 1178-1184.
75. Zlotnik A, Gruenbaum BF, Mohar B, Kuts R, Gruenbaum SE, et al. (2011) The effects of estrogen and progesterone on blood glutamate levels: evidence from changes of blood glutamate levels during the menstrual cycle in women. Biol Reprod 84: 581-586.
76. Soher BJ, van Zijl PC, Duyn JH, Barker PB (1996) Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 35: 356-363.
77. Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O (1993) The concentration of N-acetyl aspartate, creatine+phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging 11: 799-806.
78. Schuff N, Ezekiel F, Gamst AC, Amend DL, Capizzano AA, et al. (2001) Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 45: 899-907.
79. Fan G, Wu Z, Pan S, Guo Q (2003) Quantitative study of MR T1 and T2 relaxation times and 1HMRS in gray matter of normal adult brain. Chin Med J (Engl) 116: 400-404.
80. Cudalbu C, Mlynárik V, Xin L, Gruetter R (2009) Quantification of in vivo short echo-time proton magnetic resonance spectra at 14.1 T using two different approaches of modelling the macromolecule spectrum. Measurement Science and Technology 20: 104034.